Back to UBS Group AG UBS Group AG

SVASVA
27 quarters

Position history for UBS Group AGUBS Group AG's holdings in SINOVAC BIOTECH LTD

UBS Group AG holds 2,479 shares of SVA (SINOVAC BIOTECH LTD), worth $16,039 as of 2026-Q2. The position was increased (+11.2% shares).

Current Value

$16,039

Current Shares

2,479

Total Value Change

-$25,961

Total Shares Change

-4,078

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2,479
+11.2%
$16,0390.0%$6.47
14
2026-Q1
Decreased
2,229
-75.8%
$14,4220.0%$6.47
0
2025-Q4
Increased
9,222
+315.0%
$59,6660.0%$6.47
23
2025-Q3
Increased
2,222
+0.4%
$14,3760.0%$6.47
12
2025-Q2
New
2,213
-
$14,3180.0%—
27
2024-Q3
Exited
0
-100.0%
$00.0%—
0
2024-Q2
Decreased
1,557
-25.7%
$10,0740.0%—
0
2024-Q1
New
2,095
-
$13,5550.0%—
27
2023-Q4
Exited
0
-100.0%
$00.0%—
0
2023-Q3
Unchanged
9,095
0.0%
$58,8450.0%—
0
2023-Q2
New
9,095
-
$58,8450.0%—
32
2022-Q4
Exited
0
-100.0%
$00.0%—
0
2022-Q3
Decreased
2,095
-77.0%
$14,0000.0%—
0
2022-Q2
New
9,095
-
$59,0000.0%—
32
2022-Q1
Exited
0
-100.0%
$00.0%—
0
2021-Q4
Unchanged
9,095
0.0%
$59,0000.0%—
0
2021-Q3
Unchanged
9,095
0.0%
$59,0000.0%—
0
2021-Q2
Unchanged
9,095
0.0%
$59,0000.0%—
0
2021-Q1
Unchanged
9,095
0.0%
$00.0%—
0
2020-Q4
Unchanged
9,095
0.0%
$58,0000.0%—
0
2020-Q3
Unchanged
9,095
0.0%
$59,0000.0%—
0
2020-Q2
Increased
9,095
+6.3%
$59,0000.0%—
15
2020-Q1
Unchanged
8,557
0.0%
$55,0000.0%—
0
2019-Q4
Increased
8,557
+30.5%
$55,0000.0%—
18
2019-Q3
Unchanged
6,557
0.0%
$00.0%—
0
2019-Q2
Unchanged
6,557
0.0%
$00.0%—
0
2019-Q1
New
6,557
-
$42,0000.0%—
31

Other major holders of SVA: RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used